Bandingkan Harga & Kinerja Pikko Land Development Tbk. (RODA) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Pikko Land Development Tbk. dan Organon Pharma Indonesia Tbk.: Pikko Land Development Tbk. diperdagangkan di Rp65 (kapitalisasi pasar 924,26 M, volume 24 jam 25,34 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Pikko Land Development Tbk. jauh lebih besar — sekitar 8,9× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| RODA | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 924,26 M | 104,4 M |
Volume | 25,34 jt | — |
Lot | 253,36 rb | — |
Perputaran | 1,63 M | — |
Harga Rata-rata | 64,29 | — |
Nilai Transaksi | 1,63 M | — |
Harga Ekuilibrium Indikatif | 65 | — |
Volume Ekuilibrium Indikatif | 3,17 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Pikko Land Development Tbk.
PT Pikko Land Development Tbk (formerly PT Royal Oak Development Asia) was established called PT Roda Panggon Harapan based on notarial deed No.83 dated October 15, 1984 of Benny Kristianto, S.H., a public notary in Jakarta. The Company business is in property development, where most of its project located around Jakarta & Tanggerang. One of the biggest project is Simprug Estate in Poris, Tanggerang.
Selengkapnya di halaman RODA →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
